Detection of the axonal injury marker, amyloid precursor protein, in the blood of young MS patients (age ~15 years) may indicate that neuronal degeneration occurs at an early stage of disease development and/or is indicative of its progression [79]. This evidence concerns the gene APP and myeloid sarcoma.